News TLC BioSciences Corp.

Stocks

End-of-day quote Taipei Exchange 2026-10-22			5-day change	1st Jan Change
371.50 ^TWD	-7.47%		-11.12%	-

10-19	Tlc Biosciences Corp. Announces Positive Topline Results from Pivotal Phase 3 Trial of TLC590 for the Management of Postsurgical Pain Following Bunionectomy	CI
08-14	TLC BioSciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

10-19	Tlc Biosciences Corp. Announces Positive Topline Results from Pivotal Phase 3 Trial of TLC590 for the Management of Postsurgical Pain Following Bunionectomy	CI
08-14	TLC BioSciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-25	TLC BioSciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI